18F-FDG PET in Other Malignancies
| Tumor type | Results | Study |
|---|---|---|
| Mesothelioma | Sensitivity, 91% | Bénard et al. (55) |
| Specificity, 100% | ||
| Hepatic tumors | Earlier depiction of response to therapy with 18F-FDG than with CT or tumor markers | Nagata et al. (56) |
| Germ cell carcinoma | Accuracy of 90% in seminomas and 81% in nonseminomas | Cremerius et al. (57) |
| Musculoskeletal sarcoma | Sensitivity, 81% | Adler et al. (58) |
| Specificity, 100% |